160313-69-9

Basic information

• Product Name: ETHYL 4-BROMO-3-METHYLBENZOATE
• Synonyms: ETHYL 4-BROMO-3-METHYLBENZOATE;Benzoic acid, 4-bromo-3-methyl-, ethyl ester;Ethyl 4- broMo-3Methylbnzoate ethyl;ethyl 3-methyl-4-bromobenzoate
• CAS NO: 160313-69-9
• Molecular Formula: C₁₀H₁₁BrO₂
• Molecular Weight: 243.1
• Product Categories: Acids & Esters;Bromine Compounds
• Mol File: 160313-69-9.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 275°C(lit.)
• Flash Point: 136.792 °C
• Appearance: white crystalline power
• Density: 1.379 g/cm³
• Vapor Pressure: 0.001mmHg at 25°C
• Refractive Index: 1.5460 to 1.5500
• Storage Temp.: Inert atmosphere,Room Temperature
• CAS DataBase Reference: ETHYL 4-BROMO-3-METHYLBENZOATE(CAS DataBase Reference)
• NIST Chemistry Reference: ETHYL 4-BROMO-3-METHYLBENZOATE(160313-69-9)
• EPA Substance Registry System: ETHYL 4-BROMO-3-METHYLBENZOATE(160313-69-9)

Safety Data

• Hazardous Substances Data: 160313-69-9(Hazardous Substances Data)

Usage

Chemical Properties

Pale red liquid or solid

InChI:InChI=1/C10H11BrO2/c1-3-13-10(12)8-4-5-9(11)7(2)6-8/h4-6H,3H2,1-2H3

Upstream product

• 64-17-5 ethanol 
• 7697-28-1 4-bromo-3-methylbenzoic acid 

Downstream Products

• 254740-64-2 4'-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-N-(4,5-dimethyl-3-isoxazolyl)-2'-(ethoxymethyl) [1,1'-biphenyl]-2-sulfonamide 
• 813424-51-0 ethyl (S)-2-{[2-(methoxymethyl)pyrrolidin-1-yl]methyl}biphenyl-4-carboxylate 

Relevant articles and documents

Preparation method and application of 3-methyl-4-formaldoxime ethyl benzoate

The invention relates to a preparation method of 3-methyl-4-formaldoxime ethyl benzoate. The method comprises the steps that S1, 4-bromo-3-methylbenzoic acid is dissolved into ethanol, an acylating chlorination reagent is added for conducting an reaction

Homogenous suspension of immunopotentiating compounds and uses thereof

The present invention generally relates to homogeneous suspensions of small molecule immune potentiators (SMIPs) that are capable of stimulating or modulating an immune response in a subject in need thereof. The homogeneous suspensions may be used in combinations with various antigens or adjuvants for vaccine therapies.

N,N-DISUBSTITUTED AMINOALKYLBIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS

Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions that include the compounds described herein, and methods of using such antagonists of PGD2 receptors, alone or in combination with other compounds, for treating respiratory, cardiovascular, and other PGD2-dependent or PGD2-mediated conditions or diseases.